What are the three layers of DHF to ISO 13485 mapping and what do most companies miss?
Answered at 17:45 in #474: Behind the QMSR Audits: The Top 5 FDA Citations & Risk Management Pitfalls · Global Medical Device Podcast powered by Greenlight Guru
What are the three layers of DHF to ISO 13485 mapping and what do most companies miss?
Real mapping has three layers. Layer one is terminology—DHF maps to design and development file, DMR to medical device file, DHR to production and service record—which takes an afternoon to update SOPs but proves nothing about correctness. Layer two is clause-level conformity, where for every subclause you must point to the record that satisfies it; for example, design transfer under Clause 7.3.8 requires documented verification that outputs are suited, which most companies never did. Layer three is verifying that when a device changed in 2023, that change followed through change evaluation into the risk file, medical device file, and supplier controls.
Full answer and detailsRead the whole answer, key facts and every other question from this episode
In short
Real mapping has three layers.
Nikhil Mangali, Vice President of Quality at Capstone Medical · #474: Behind the QMSR Audits: The Top 5 FDA Citations & Risk Management Pitfalls · Global Medical Device Podcast powered by Greenlight Guru · answer at 17:45
Quote to remember
“Your own risk documentation tells you that. Your own file is now the navigation instrument for an investigator.”
— Nikhil Mangali
The full answer · about 4 min
Real mapping has three layers. Layer one is terminology—DHF maps to design and development file, DMR to medical device file, DHR to production and service record—which takes an afternoon to update SOPs but proves nothing about correctness. Layer two is clause-level conformity, where for every subclause you must point to the record that satisfies it; for example, design transfer under Clause 7.3.8 requires documented verification that outputs are suited, which most companies never did. Layer three is verifying that when a device changed in 2023, that change followed through change evaluation into the risk file, medical device file, and supplier controls.
Key facts
- QMSR effective for seven months at time of episode recording
- Proposed rule released three and a half years before QMSR implementation
- Risk management process must run through product realization under ISO 13485 Clause 7.3, not just at design validation
- FDA compliance program organizes inspection around six QMS areas plus four FDA-specific requirements
- July 2024: Nikhil Mangali promoted to Vice President of Quality at Capstone Medical
People, companies and topics mentioned
More answers from this episode
- 0:54What are the top 5 FDA citations from QMSR audits according to real inspection data?
- 3:00Why is risk management the most cited QMSR compliance violation?
- 5:15What specific supplier control issues are FDA citing under QMSR?
- 14:20How should legacy medical devices with older DHF files approach QMSR compliance?
- 20:10What is the four-phase gap assessment process for QMSR compliance?